| For: | Mangolini A, de Stephanis L, Aguiari G. Role of calcium in polycystic kidney disease: From signaling to pathology. World J Nephrol 2016; 5(1): 76-83 [PMID: 26788466 DOI: 10.5527/wjn.v5.i1.76] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v5/i1/76.htm |
| Number | Citing Articles |
| 1 |
Kathrin Burgmaier, Bénédicte Buffin-Meyer, Julie Klein, Brian Becknell, Daryl McLeod, Jan Boeckhaus, Oliver Gross, Claudia Dafinger, Justyna Siwy, Stéphane Decramer, Franz Schaefer, Max C Liebau, Joost P Schanstra. Urinary peptide signature distinguishes autosomal recessive polycystic kidney disease from other causes of chronic kidney disease. Clinical Kidney Journal 2025; 18(5) doi: 10.1093/ckj/sfaf093
|
| 2 |
Jonathan Pacheco, Luis Vaca. Store-Operated Ca²⁺ Entry (SOCE) Pathways. Advances in Experimental Medicine and Biology 2017; 993 doi: 10.1007/978-3-319-57732-6_10
|
| 3 |
Aylin Kılıç Yazgan, Oya Topaloğlu, Fatma Neslihan Çuhacı, Didem Özdemir, Afra Alkan, Mehmet Kılıç, Reyhan Ersoy, Bekir Çakır. Mapping of parathyroid neoplasms based on grey scale ultrasound images and histopathological whole slide images. Annals of Diagnostic Pathology 2020; 46 doi: 10.1016/j.anndiagpath.2020.151492
|
| 4 |
Yongzhan Sun, Quan Zou, Huizheng Yu, Xiaoping Yi, Xudan Dou, Yu Yang, Zhiheng Liu, Hong Yang, Junya Jia, Yupeng Chen, Shao-Kai Sun, Lirong Zhang. Melanin-like nanoparticles slow cyst growth in ADPKD by dual inhibition of oxidative stress and CREB. EMBO Molecular Medicine 2025; 17(1) doi: 10.1038/s44321-024-00167-2
|
| 5 |
Irene Capelli, Sarah Lerario, Francesca Ciurli, Gian Marco Berti, Valeria Aiello, Michele Provenzano, Gaetano La Manna. Investigational agents for autosomal dominant polycystic kidney disease: preclinical and early phase study insights. Expert Opinion on Investigational Drugs 2024; 33(5) doi: 10.1080/13543784.2024.2342327
|
| 6 |
Wen-Di Ge, Tian-Tian Du, Cao-Yang Wang, Lu-Ning Sun, Yong-Qing Wang. Calcium signaling crosstalk between the endoplasmic reticulum and mitochondria, a new drug development strategies of kidney diseases. Biochemical Pharmacology 2024; 225 doi: 10.1016/j.bcp.2024.116278
|
| 7 |
David Alencar Araripe, Margarita Iljin, Hester Bange, Leo S. Price, Rongfang Liu, Daan van der Es, Laura H. Heitman, Dorien J.M. Peters, Gerard J.P. van Westen. From phenotypic screening to target and compound prioritization for autosomal dominant polycystic kidney disease. SLAS Discovery 2026; 44 doi: 10.1016/j.slasd.2026.100338
|
| 8 |
Qasim Al-orjani, Lubna A. Alshriem, Gillian Gallagher, Raghad Buqaileh, Neela Azizi, Wissam AbouAlaiwi. Mechanistic Insights into the Pathogenesis of Polycystic Kidney Disease. Cells 2025; 14(15) doi: 10.3390/cells14151203
|
| 9 |
Megan S. Valentine, Junji Yano, Judith Van Houten. A Novel Role for Polycystin-2 (Pkd2) in P. tetraurelia as a Probable Mg2+ Channel Necessary for Mg2+-Induced Behavior. Genes 2019; 10(6) doi: 10.3390/genes10060455
|
| 10 |
Johannes Leierer, Paul Perco, Benedikt Hofer, Susanne Eder, Alexander Dzien, Julia Kerschbaum, Michael Rudnicki, Gert Mayer. Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease. International Journal of Molecular Sciences 2021; 22(13) doi: 10.3390/ijms22136885
|
| 11 |
Luís Perpétuo, Visith Thongboonkerd, Rita Ferreira, Sofia Guedes, Francisco Amado, Rui Vitorino. Re-Analysis of Published Datasets in Search of Novel Urogenital Diseases
Biomarkers. Current Protein & Peptide Science 2022; 23(11) doi: 10.2174/1389203723666220929155542
|
| 12 |
Ingrid Fliniaux, Emmanuelle Germain, Valerio Farfariello, Natalia Prevarskaya. TRPs and Ca2+ in cell death and survival. Cell Calcium 2018; 69 doi: 10.1016/j.ceca.2017.07.002
|
| 13 |
Bonnie L. Blazer-Yost, Darren P. Wallace. Studies of Epithelial Transporters and Ion Channels. Physiology in Health and Disease 2020; doi: 10.1007/978-3-030-55454-5_29
|
| 14 |
Cassandra Millet-Boureima, Stephanie He, Thi Bich Uyen Le, Chiara Gamberi. Modeling Neoplastic Growth in Renal Cell Carcinoma and Polycystic Kidney Disease. International Journal of Molecular Sciences 2021; 22(8) doi: 10.3390/ijms22083918
|
| 15 |
Murali K Yanda, Vartika Tomar, Robert Cole, William B. Guggino, Liudmila Cebotaru. The Mitochondrial Ca2+ import complex is altered in ADPKD. Cell Calcium 2022; 101 doi: 10.1016/j.ceca.2021.102501
|
| 16 |
Murali K. Yanda, Qiangni Liu, Valeriu Cebotaru, William B. Guggino, Liudmila Cebotaru. Role of calcium in adult onset polycystic kidney disease. Cellular Signalling 2019; 53 doi: 10.1016/j.cellsig.2018.10.003
|
| 17 |
Rebecca V. Walker, Jennifer L. Keynton, Daniel T. Grimes, Vrinda Sreekumar, Debbie J. Williams, Chris Esapa, Dongsheng Wu, Martin M. Knight, Dominic P. Norris. Ciliary exclusion of Polycystin-2 promotes kidney cystogenesis in an autosomal dominant polycystic kidney disease model. Nature Communications 2019; 10(1) doi: 10.1038/s41467-019-12067-y
|
| 18 |
Miroslava Brndiarova, Julia Kvassayova, Jarmila Vojtkova, Matus Igaz, Tomas Buday, Jana Plevkova. Best Practice in Health Care. Advances in Experimental Medicine and Biology 2021; 1335 doi: 10.1007/5584_2021_617
|
| 19 |
G. Toteda, D. Vizza, S. Lupinacci, A. Perri, M. F. Scalise, C. Indiveri, F. Puoci, O. I. Parisi, D. Lofaro, A. La Russa, P. Gigliotti, F. Leone, L. Pochini, R. Bonofiglio. Olive leaf extract counteracts cell proliferation and cyst growth in anin vitromodel of autosomal dominant polycystic kidney disease. Food & Function 2018; 9(11) doi: 10.1039/C8FO01481G
|
| 20 |
. 2019; doi: 10.70675/e81d5d41z63f6z4620za1ccz4e8ad6a0bfdc
|
| 21 |
Anastasia V. Sudarikova, Valeriia Y. Vasileva, Regina F. Sultanova, Daria V. Ilatovskaya. Recent advances in understanding ion transport mechanisms in polycystic kidney disease. Clinical Science 2021; 135(21) doi: 10.1042/CS20210370
|
| 22 |
Jingyuan Gao, Xiaoyong Yu. Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Role in Cystogenesis and Novel Therapeutic Approaches. Biomedicines 2025; 13(7) doi: 10.3390/biomedicines13071596
|
| 23 |
Humayra Afrin, Jielu Hao Robichaud, Usama Qamar, Peter C. Harris, Navin Gupta. Kidney organoids demonstrate that PTH1R drives a cystogenic cAMP-pPKA-pCREB axis in developmental polycystic kidney disease. American Journal of Physiology-Renal Physiology 2025; 329(2) doi: 10.1152/ajprenal.00056.2025
|
| 24 |
Murali K. Yanda, Qiangni Liu, Valeriu Cebotaru, William B. Guggino, Liudmila Cebotaru. Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca2+ in knock-out mouse models of polycystic kidney disease. Journal of Biological Chemistry 2017; 292(43) doi: 10.1074/jbc.M117.803775
|
| 25 |
Murali K. Yanda, Cristian Ciobanu, William B. Guggino, Liudmila Cebotaru. CFTR and PC2, partners in the primary cilia in autosomal dominant polycystic kidney disease. American Journal of Physiology-Cell Physiology 2023; 325(3) doi: 10.1152/ajpcell.00197.2023
|
| 26 |
Yan Tang, JungWoo Yang, Wang Zheng, Jingfeng Tang, Xing-Zhen Chen, Jianzheng Yang, Zuocheng Wang. Polycystin-1 Inhibits Cell Proliferation through Phosphatase PP2A/B56α. BioMed Research International 2019; 2019 doi: 10.1155/2019/2582401
|
| 27 |
Takashi Shiromizu, Mizuki Yuge, Kousuke Kasahara, Daishi Yamakawa, Takaaki Matsui, Yasumasa Bessho, Masaki Inagaki, Yuhei Nishimura. Targeting E3 Ubiquitin Ligases and Deubiquitinases in Ciliopathy and Cancer. International Journal of Molecular Sciences 2020; 21(17) doi: 10.3390/ijms21175962
|
| 28 |
Tao Xu, Meihan Chen, Qingwen Xu, Cheng Xue, Lili Fu, Kun Ling, Jinghua Hu, Changlin Mei. Anoctamin 1 Inhibition Suppresses Cystogenesis by Enhancing Ciliogenesis and the Ciliary Dosage of Polycystins. Frontiers in Bioscience-Landmark 2022; 27(7) doi: 10.31083/j.fbl2707216
|
| 29 |
Yejin Ahn, Jong Hoon Park. Novel Potential Therapeutic Targets in Autosomal Dominant Polycystic Kidney Disease from the Perspective of Cell Polarity and Fibrosis. Biomolecules & Therapeutics 2024; 32(3) doi: 10.4062/biomolther.2023.207
|
| 30 |
Annarita Di Mise, Grazia Tamma, Marianna Ranieri, Mariangela Centrone, Lambertus van den Heuvel, Djalila Mekahli, Elena N. Levtchenko, Giovanna Valenti. Activation of Calcium-Sensing Receptor increases intracellular calcium and decreases cAMP and mTOR in PKD1 deficient cells. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-23732-5
|
| 31 |
E Y Salinas, A Aryaei, N Paschos, E Berson, H Kwon, J C Hu, K A Athanasiou. Shear stress induced by fluid flow produces improvements in tissue-engineered cartilage. Biofabrication 2020; 12(4) doi: 10.1088/1758-5090/aba412
|
| 32 |
Xin Chou, Xiaohu Li, Kunpeng Ma, Yue Shen, Zhen Min, Wusheng Xiao, Jingbo Zhang, Qing Wu, Daoyuan Sun. N-methyl-d-aspartate receptor 1 activation mediates cadmium-induced epithelial-mesenchymal transition in proximal tubular cells. Science of The Total Environment 2023; 904 doi: 10.1016/j.scitotenv.2023.166955
|
| 33 |
Allison L. Brill, Barbara E. Ehrlich. Polycystin 2: A calcium channel, channel partner, and regulator of calcium homeostasis in ADPKD. Cellular Signalling 2020; 66 doi: 10.1016/j.cellsig.2019.109490
|
| 34 |
Aryendu Kumar Saini, Rakesh Saini, Shubham Singh. Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspects. Molecular Medicine 2020; 26(1) doi: 10.1186/s10020-020-00246-3
|
| 35 |
Chau My Ta, Thuy N. Vien, Leo C.T. Ng, Paul G. DeCaen. Structure and function of polycystin channels in primary cilia. Cellular Signalling 2020; 72 doi: 10.1016/j.cellsig.2020.109626
|
| 36 |
Hannah M Mitchison, Enza Maria Valente. Motile and non‐motile cilia in human pathology: from function to phenotypes. The Journal of Pathology 2017; 241(2) doi: 10.1002/path.4843
|
| 37 |
Je Yeong Ko. Cystogenesis. Advances in Experimental Medicine and Biology 2016; 933 doi: 10.1007/978-981-10-2041-4_5
|
| 38 |
Xiong Liu, Jingfeng Tang, Xing-Zhen Chen. Role of PKD2 in the endoplasmic reticulum calcium homeostasis. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.962571
|
| 39 |
Humayra Afrin, Usama Qamar, Jielu Hao Robichaud, Mohammad Ellabbad, Peter C. Harris, Navin Gupta. Kidney organoid models of polycystic kidney disease: challenges and future directions. American Journal of Physiology-Renal Physiology 2025; 329(1) doi: 10.1152/ajprenal.00116.2025
|
| 40 |
Kirill S. Nikolsky, Arthur T. Kopylov, Valeriya I. Nakhod, Natalia V. Potoldykova, Dmitry V. Enikeev, Tatiana V. Butkova, Liudmila I. Kulikova, Kristina A. Malsagova, Vladimir R. Rudnev, Denis V. Petrovskiy, Alexander A. Izotov, Anna L. Kaysheva. Plasma proteome fingerprint in kidney diseases. Frontiers in Molecular Biosciences 2025; 11 doi: 10.3389/fmolb.2024.1494779
|
| 41 |
Steven J. Kleene, Nancy K. Kleene. Inward Ca2+ current through the polycystin-2-dependent channels of renal primary cilia. American Journal of Physiology-Renal Physiology 2021; 320(6) doi: 10.1152/ajprenal.00062.2021
|
| 42 |
E. F. Andreeva, N. D. Savenkova. Treatment of autosomal recessive and autosomal dominant polycystic kidney disease. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2019; 64(2) doi: 10.21508/1027-4065-2019-64-2-22-29
|
| 43 |
Annarita Di Mise, Angela Ferrulli, Mariangela Centrone, Maria Venneri, Marianna Ranieri, Grazia Tamma, Rosa Caroppo, Giovanna Valenti. Functional Coupling of Calcium-Sensing Receptor and Polycystin-2 in Renal Epithelial Cells: Physiological Role and Potential Therapeutic Target in Polycystic Kidney Disease. International Journal of Molecular Sciences 2025; 26(24) doi: 10.3390/ijms262412004
|
| 44 |
Murali K. Yanda, Qiangni Liu, Liudmila Cebotaru. A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector. Journal of Biological Chemistry 2018; 293(29) doi: 10.1074/jbc.RA118.001846
|